Simpson Grade: an Opportunity to Reassess the Need for Complete Resection of Meningiomas
Overview
Affiliations
Background: The relevance of the Simpson grading system as a predictor of meningioma progression or recurrence in modern neurosurgical practice has recently been called into question. The aim of our study was to compare the risk of progression/recurrence of tumours that had been treated with different Simpson grade resections in a contemporary population of benign (WHO grade I) meningioma patients.
Method: One hundred eighty-three patients with histologically confirmed WHO grade I meningioma were retrospectively analysed. All patients underwent first-time craniotomy as their initial therapy between 2004 and 2012. Univariate analysis was performed using log-rank testing and Kaplan-Meier analysis for progression/recurrence-free survival. Multivariate analysis was performed using Cox proportional hazards regression modelling.
Results: The three-year progression/recurrence-free survival rates for patients receiving Simpson grade 1, 2 or 4 resections were 95 %, 87 % and 67 %, respectively. Simpson grade 4 resections progressed/recurred at a significantly greater rate than Simpson grade 1 resections (hazard ratio [HR] = 3.26, P = 0.04), whereas Simpson grade 2 resections did not progress/recur at a significantly greater rate than Simpson grade 1 resections (HR = 1.78, P = 0.29). Subtotal resections progressed/recurred at a significantly greater rate than gross-total resections (HR = 2.47, P = 0.03).
Conclusions: Tumours that undergo subtotal resection are at a significantly greater risk of progression/recurrence than tumours that undergo gross-total resection. Gross-total resection should therefore be the aim of surgery. However, given modern access to follow-up imaging and stereotactic radiosurgery, these results should not be used to justify overly 'heroic' tumour resection.
Molecular classification to refine surgical and radiotherapeutic decision-making in meningioma.
Wang J, Patil V, Landry A, Gui C, Ajisebutu A, Liu J Nat Med. 2024; 30(11):3173-3183.
PMID: 39169220 PMC: 11564112. DOI: 10.1038/s41591-024-03167-4.
Atypical meningiomas compared to other WHO Grade 2 meningiomas: Histological features and prognosis.
Ajlan A, Almeshari S, Basindwah S, Aljohani M, Alharbi Y, Aldhowaihy F Neurosciences (Riyadh). 2024; 29(2):96-102.
PMID: 38740393 PMC: 11305365. DOI: 10.17712/nsj.2024.2.20230091.
Gross-total resection in optic nerve sheath meningiomas: minimally invasive and cosmetic pleasing.
Dai Q, Li X, Fang Y, Shen B, Wei J, Xie Q Graefes Arch Clin Exp Ophthalmol. 2024; 262(8):2661-2673.
PMID: 38502351 PMC: 11271350. DOI: 10.1007/s00417-024-06447-4.
Dadario N, Sughrue M J Neurol Surg B Skull Base. 2024; 85(2):145-155.
PMID: 38449587 PMC: 10914467. DOI: 10.1055/a-2021-8852.
Interdisciplinary Therapeutic Approaches to Atypical and Malignant Meningiomas.
Trakolis L, Petridis A Cancers (Basel). 2023; 15(17).
PMID: 37686527 PMC: 10486693. DOI: 10.3390/cancers15174251.